Finance

Lists
TTI:CVE
Thiogenesis Therapeutics Corp
CA$0.49
0.00%
(0.00) 1D
Oct 1, 3:45:01 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for TTI...
Mkt. cap
34.29M
Avg. vol.
52.49K
Volume
0.00
52-wk high
CA$0.81
52-wk low
CA$0.44
EPS
-CA$0.12
Beta
0.44
Shares outstanding
69.98M
Mkt. cap
34.29M
Avg. vol.
52.49K
Volume
0.00
52-wk high
CA$0.81
52-wk low
CA$0.44
EPS
-CA$0.12
Beta
0.44
Shares outstanding
69.98M
News stories
From web sources and news partners
About Thiogenesis Therapeutics Corp
CEO-
Employees-
Founded2018
HeadquartersToronto, Ontario, Canada
SectorBiotechnology
Websitethiogenesis.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.92M
1.27M
579.55K
1.24M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
471.84K
464.40K
338.28K
242.34K
Operating expense
2.39M
1.73M
917.82K
1.48M
Total operating expenses
2.39M
1.73M
917.82K
1.48M
Operating income
-2.39M
-1.73M
-917.82K
-1.48M
Other non operating income
-
-
-
-
EBT including unusual items
-2.38M
-1.73M
-911.82K
-1.49M
EBT excluding unusual items
-2.38M
-1.73M
-911.82K
-1.49M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.38M
-1.73M
-911.82K
-1.49M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
6.45K
4.42K
51.00
2.18K
Interest expense
-
-
-
-
Net interest expenses
6.45K
4.42K
51.00
2.18K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps